Global Patent Index - EP 1080110 A2

EP 1080110 A2 20010307 - USE OF ACTIVATED T CELLS, NERVOUS SYSTEM-SPECIFIC ANTIGENS FOR TREATING DISORDERS OF THE NEVROUS SYSTEM

Title (en)

USE OF ACTIVATED T CELLS, NERVOUS SYSTEM-SPECIFIC ANTIGENS FOR TREATING DISORDERS OF THE NEVROUS SYSTEM

Title (de)

VERWENDUNG VON AKTIVIERTEN T ZELLEN, NERVENSYSTEM-SPEZIFISCHEN ANTIGENE ZUR BEHANDLUND VON ERKRANKUNGEN DES NERVENSYSTEMS

Title (fr)

LYMPHOCYTES T ACTIVES, ANTIGENES SPECIFIQUES DU SYSTEME NERVEUX ET LEUR UTILISATION

Publication

EP 1080110 A2 20010307 (EN)

Application

EP 99923190 A 19990519

Priority

  • IL 12455098 A 19980519
  • US 9910953 W 19990519
  • US 9814715 W 19980721
  • US 21827798 A 19981222

Abstract (en)

[origin: WO9960021A2] Compositions and methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected using activated T cells that recognize an antigen of the nervous system or a peptide derived therefrom or a derivative thereof to promote nerve regeneration or to prevent or inhibit neuronal degeneration within the nervous system. Treatment involves administering an NS-specific antigen or peptide derived therefrom or a derivative thereof, or a nucleotide sequence encoding said antigen or peptide, to promote nerve regeneration or to prevent or inhibit neuronal degeneration in the nervous system, either the central nervous system or the peripheral nervous system. The NS-specific activated T cells can be administered alone or in combination with NS-specific antigen or peptide derived therefrom or a derivative thereof or a nucleotide sequence encoding said antigen or peptide, or any combination thereof.

IPC 1-7

C07K 14/47; C07K 14/705; C12N 5/06; A61K 39/00

IPC 8 full level

C12N 15/09 (2006.01); A61K 31/711 (2006.01); A61K 35/26 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61P 25/28 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); A61K 48/00 (2006.01)

CPC (source: EP)

A61K 38/1709 (2013.01); A61K 39/0007 (2013.01); A61K 39/4611 (2023.05); A61K 39/46432 (2023.05); A61P 25/28 (2018.01); A61K 48/00 (2013.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9960021 A2 19991125; WO 9960021 A3 20000615; CA 2328612 A1 19991125; EP 1080110 A2 20010307; JP 2003532618 A 20031105

DOCDB simple family (application)

US 9910953 W 19990519; CA 2328612 A 19990519; EP 99923190 A 19990519; JP 2000549639 A 19990519